Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #41   US Drug Pricing (Part 2)     Healthcare costs containment and particularly drug pricing is becoming a major issue in all countries. Although the costs of drugs only represent five to seven percent of overall healthcare costs, prescription drug […]

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT   We wish all our friends in the United States a Happy Thanksgiving Holiday               November 27, 2019

  Meeting us at BIOFIT2019  to discuss about your needs in business development : – Prospection by phone & email to get new customers in pharma, biotech, dermocosmetic in Europe & US.   – Preparation & Representation to business conventions (Bio-Europe, Bio-US)   Info on the event :https://www.biofit-event.com/    

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #40     Merck receives European Approval for Ervebo its Ebola Vaccine       On Monday, the European Commission approved Merck’s Ervebo, known as V920, the world’s first Ebola vaccine, just a few days after the European Medicines Agency’s Committee for […]

      Parallèles entre exploration spatiale et exploration du cerveau   Posté le 6 novembre 2019 dans Communiqués de presse par Charles Sagnes.   L’exploration spatiale et l’exploration du cerveau, deux domaines qui semblent très éloignés sur le papier, ont, en fait, beaucoup de points communs et peuvent chacun apprendre l’un de l’autre pour le futur. […]

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #38     China approves Oligomannate for the treatment of Alzheimer’s disease     Shanghai Green Valley Pharmaceuticals (Green Valley) announced that China’s National Medical Products Administration (NMPA) has given a conditional approval to Oligomannate (GV-971) as a new drug for the […]

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #37       Stephen Hahn selected to become the next US FDA Commissioner       President Donald Trump has nominated Stephen Hahn as the next US FDA commissioner. Hahn, a radiation oncologist is currently chief medical executive of the University […]